Menu

Corbus Pharmaceuticals Holdings, Inc. CRBP

Full chart Compare
Set alert

Price alert · CRBP

All alert types
3.70 USD +0.63 (+20.60%)

Nov 9, 2026, 2:42 PM EST

3.11 Day range 3.72
2.81 52-week range 12.88
YTD
-54.52%
1 year
-64.81%

Revenue & Expenses

Other Income → Expenses: $12.18MExpenses → Selling, General & Admin: $20.43MExpenses → Research & Development: $36.45MExpenses → Interest Expense: $1.83MGross Profit → Expenses: $881.71KRevenue → Gross Profit: $881.71KNet Loss → Expenses: $45.64MOther Income$12.18MGross Profit$881.71KNet Loss$45.64MExpenses$58.70MSelling, General & Admin$20.43MResearch & Development$36.45MInterest Expense$1.83MRevenue$881.71K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRBP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-85.31M-48.72M-45.08M-39.84M-55.99M
-78.54M-40.21M-44.60M-42.35M-45.64M
-5.90-3.68-10.31-10.15-11.15
CRBP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
29.16M17.87M14.39M17.67M25.68M
168.19M155.88M28.27M66.31M107.73M
20.69M13.45M35.18M33.32M38.62M
1.63M3.24M20.89M25.09M26.59M
147.50M142.43M-6.91M32.99M69.11M
CRBP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-64.49M-41.79M-36.10M-37.54M-48.18M
-1.64M-121.31M35.64M30.07M-73.42M
77.43M166.58M-2.82M-533.62K60.82M
-7.00K00-5.35K-30.27K
11.29M3.47M-3.28M-8.00M-60.78M